Abstract
Cell death is a major component of developmental programs. Controlled killing of specific cells at appropriate time points is required for normal growth and shaping of organisms. However, cellular demolition can also result in a variety of pathologies that are frequently fatal, when implemented inappropriately. Delineation of cell death mechanisms has been greatly facilitated by the use of simple model organisms such as the nematode worm Caenorhabditis elegans. Research in C. elegans has proven instrumental for the elucidation of the molecular mechanisms underlying both apoptotic and necrotic cell death. Here, we introduce the C. elegans model and review the current understanding of cell death pathways in this organism. We further focus on recent studies implicating autophagy, the main cellular process for bulk protein and organelle recycling, in nematode cell death. These studies reveal that autophagic mechanisms have a prominent role in both apoptosis and necrosis. We survey the relevant findings in C. elegans and also consider the contribution of autophagy in cell death in other experimental systems. Comparative analysis suggests that the involvement of autophagy in cell death is evolutionary conserved in metazoans. Thus, interfering with the autophagic process may facilitate therapeutic intervention in human pathologies where aberrant cell death is a contributing factor.
Keywords: Apoptosis, Autophagy, Beclin, Caenorhabditis elegans, Excitotoxicity, Lysosome, Necrosis, Neurodegeneration
Current Pharmaceutical Design
Title: Autophagy and Cell Death in Caenorhabditis elegans
Volume: 14 Issue: 2
Author(s): Nektarios Tavernarakis and Chrysanthi Samara
Affiliation:
Keywords: Apoptosis, Autophagy, Beclin, Caenorhabditis elegans, Excitotoxicity, Lysosome, Necrosis, Neurodegeneration
Abstract: Cell death is a major component of developmental programs. Controlled killing of specific cells at appropriate time points is required for normal growth and shaping of organisms. However, cellular demolition can also result in a variety of pathologies that are frequently fatal, when implemented inappropriately. Delineation of cell death mechanisms has been greatly facilitated by the use of simple model organisms such as the nematode worm Caenorhabditis elegans. Research in C. elegans has proven instrumental for the elucidation of the molecular mechanisms underlying both apoptotic and necrotic cell death. Here, we introduce the C. elegans model and review the current understanding of cell death pathways in this organism. We further focus on recent studies implicating autophagy, the main cellular process for bulk protein and organelle recycling, in nematode cell death. These studies reveal that autophagic mechanisms have a prominent role in both apoptosis and necrosis. We survey the relevant findings in C. elegans and also consider the contribution of autophagy in cell death in other experimental systems. Comparative analysis suggests that the involvement of autophagy in cell death is evolutionary conserved in metazoans. Thus, interfering with the autophagic process may facilitate therapeutic intervention in human pathologies where aberrant cell death is a contributing factor.
Export Options
About this article
Cite this article as:
Tavernarakis Nektarios and Samara Chrysanthi, Autophagy and Cell Death in Caenorhabditis elegans, Current Pharmaceutical Design 2008; 14 (2) . https://dx.doi.org/10.2174/138161208783378770
DOI https://dx.doi.org/10.2174/138161208783378770 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Changes in the Expression of the Alzheimers Disease-Associated Presenilin Gene in Drosophila Heart Leads to Cardiac Dysfunction
Current Alzheimer Research Sterol 14α-Demethylase from Trypanosomatidae Parasites as a Promising Target for Designing New Antiparasitic Agents
Current Topics in Medicinal Chemistry Modulation of Collagen Turnover in Cardiovascular Disease
Current Pharmaceutical Design The PKB/AKT Pathway in Cancer
Current Pharmaceutical Design The Role of Aryl Hydrocarbon Receptor-Regulated Cytochrome P450 Enzymes in Glioma
Current Pharmaceutical Design Reactive Oxygen Species in Myocardial Reperfusion Injury: From Physiopathology to Therapeutic Approaches
Current Pharmaceutical Biotechnology The Cardiac Conduction and Contractility Complications of Methamphetamine Use and the Relationship to Psychiatric Comorbidity: A Systematic Review
Current Psychiatry Research and Reviews Adult Stem Cells and Skeletal Muscle Regeneration
Current Gene Therapy Forensic Toxicology and Pharmacogenomics: Hype or Hope For Higher Standards in Forensic Medicine?
Current Pharmacogenomics and Personalized Medicine Cell Therapy for Myocardial Regeneration
Current Molecular Medicine Bradykinin Receptors in Ischemic Injury
Current Neurovascular Research Radionuclide Imaging in Patients with Ischemic Heart Failure
Current Medical Imaging Roles of p38-MAPK in Insulin Resistant Heart: Evidence from Bench to Future Bedside Application
Current Pharmaceutical Design Isosteviol Protects H9c2 Cells Against Hypoxia-reoxygenation by Activating ERK1/2
Cardiovascular & Hematological Disorders-Drug Targets Advances in Drug Discovery against Neglected Tropical Diseases: Human African and American Trypanosomiasis
Current Medicinal Chemistry Treating Nonthyroidal Illness Syndrome in the Critically Ill Patient: Still a Matter of Controversy
Current Drug Targets The ErbB Receptors and their Ligands in Cancer: An Overview
Current Drug Targets Imaging and Laboratory Biomarkers in Cardiovascular Disease
Current Pharmaceutical Design Catestatin: A Master Regulator of Cardiovascular Functions
Current Medicinal Chemistry The Right Ventricle: Biologic Insights and Response to Disease: Updated
Current Cardiology Reviews